CN111616218A

CN111616218A - Donkey milk powder and micromolecular peptide formula milk powder

Info

Publication number: CN111616218A
Application number: CN201910173753.5A
Authority: CN
Inventors: 王莉
Original assignee: Individual
Current assignee: Individual
Priority date: 2019-02-28
Filing date: 2019-02-28
Publication date: 2020-09-04

Abstract

The formula milk powder of donkey milk powder and micromolecular peptide comprises the following components in percentage by weight: 40-45% of the finished donkey milk powder and 48-56% of the finished small molecular peptide with the molecular weight of 1000D-180D. The preferable proportion is as follows: 35-41% of finished donkey milk powder and 52-62% of finished small molecular peptide with the molecular weight of 1000D-180D. The production process comprises the following steps: (1) taking n kg of the donkey milk powder finished product for later use. (2) Taking n kilograms of small molecular peptide with the molecular weight of 1000D-180D as a finished product. (3) Putting n kilograms of the donkey milk powder taken out and the small molecular peptides taken out into a conical stainless steel container to be uniformly stirred for later use. (4) Continuously feeding the mixed materials into a fluidized drying bed for sterilization, and drying at about 75-85 deg.C to make the water content less than or equal to 0.2%. (5) And packaging and warehousing the manufactured product after the product is qualified according to the requirements and the detection. The donkey milk powder can quickly absorb various beneficial substances in the donkey milk powder to activate cells and improve immunity under the action of the small molecular peptides.

Description

Donkey milk powder and micromolecular peptide formula milk powder

Technical Field

The invention relates to donkey milk powder and micromolecular peptide formula milk powder, in particular to special milk powder prepared by matching donkey milk powder and micromolecular peptide, which has the advantages of high nutritive value, quick absorption, good health-care performance and the like.

Background art:

with the continuous improvement of living standard of people, the requirements of people on health and longevity are higher and higher, and the people pursue to select milk powder with high nutritive value and good absorption. At present, although milk powder manufacturers produce various formula milk powders, no formula milk powder of donkey milk powder and micromolecular peptide exists. After people eat the milk powder, the milk powder is not absorbed well really, because the protein, fat, a plurality of vitamins, a plurality of trace mineral elements, a plurality of amino acids and the like contained in the milk powder are not similar to the substances needed by people, the absorption is not good, and the diarrhea phenomenon exists. The research and reference of various data and related data in ancient and modern countries indicate that the substances contained in the donkey milk powder are very close to the substances required by the human body. And the small molecular peptide is matched with the food to be eaten, so that the food is better absorbed.

Ancient physicians of China, Sun Simiao, recorded the medicinal value of donkey milk in the Qian jin Yao Fang, which is called as "sweet and cold in flavor" and can treat diseases such as diabetes, jaundice and acute angina pectoris. The Ming Dynasty Li Shizhen further indicates that the donkey milk is sweet in taste, cool and free, nontoxic and frequently heated, treats qi pathogen and relieves fever in Ben Cao gang mu. Peru in south America considers donkey milk as Wanlingxiandan to treat asthma, tracheitis, diabetes and previous glandular diseases, and the current medical practice proves that the donkey milk has good conditioning effect on various diseases, and can play roles in improving blood fat and blood pressure, improving the immunity of the organism and the like.

The small molecular peptide is a substance with extremely strong activity discovered by scientists in recent decades, is an indispensable substance in human bodies, is not alive without the small molecular peptide, does not need to be digested when being taken orally, because the small molecular peptide has extremely low molecular weight, can quickly enter cells directly, has the absorption rate of 100 percent, quickly activates the cells, repairs the denatured cells, promotes nutrition, discharges metabolites, increases the autoimmunity, and regulates and prevents diseases by peptide supplementation in developed British and Japan. In 2005, the national policy was applied to the peptide supplement, and diabetes was ranked first in the world and reduced to the fourth. In 2006, peptides are determined as national policy, national peptide supplement is provided for the whole nation, the average life of the peptides reaches 89 years, the peptide supplement is listed as a national key product development in 2002 in China, the national peptide supplement has come, and the national famous biological experts, doctor clatz, say: "Small molecule active peptides will improve human longevity by at least 20 years". The peptide initiates the nutrition revolution of the twenty-first century, and the development and the application of the peptide have epoch-making significance. The donkey milk powder and the micromolecular peptide are mixed together according to a scientific proportion for taking, and the donkey milk powder and the micromolecular peptide are preferred products for improving the health and longevity of human beings.

The invention content is as follows:

the invention aims to provide donkey milk powder and micromolecular peptide formula milk powder, which does not change the instant dissolution and color of the milk powder, does not contain any additive, and can quickly absorb various useful substances such as protein, fat, various vitamins, trace mineral elements, amino acid and the like contained in the donkey milk powder.

In order to solve the problems existing in the background technology, the invention comprises the following components in percentage by weight: 40-45% of refined donkey milk powder, 48-56% of refined small molecular peptides with the molecular weight of 1000D-180D, and the optimal proportion is as follows: 38-41% of the finished donkey milk powder, and 52-62% of refined small molecular peptides between 1000D-180D.

The production process comprises the following steps:

(1) taking n kilograms of refined donkey milk powder as a finished product for later use.

(2) Taking n kilograms of refined small molecular peptide with the molecular weight of 1000D-180D for later use.

(3) Putting n kilograms of the extracted refined donkey milk powder and n kilograms of the small molecular peptides between 1000D-180D of the refined donkey milk powder into a stainless steel conical container, and uniformly stirring for later use.

(4) Continuously feeding the mixed materials into a fluidized drying bed for sterilization, and drying at about 75-85 deg.C to make the water content less than or equal to 0.2%.

(5) And packaging and warehousing the manufactured product after the manufactured product is detected to be qualified according to the requirement.

The invention has the following beneficial effects:

the refined donkey milk powder and the refined micromolecular peptide are mixed together according to a certain proportion, and can rapidly enter human cells after being eaten by people, activate cells, repair denatured cells, promote nutrition, eliminate metabolites, improve blood fat and blood pressure, and improve the immunity of organisms.

The specific implementation mode is as follows:

the specific embodiment of the invention comprises the following components in percentage by weight: 40-45% of refined donkey milk powder, 48-56% of refined small molecular peptides with the molecular weight of 1000D-180D, and the optimal proportion is as follows: 38-41% of refined donkey milk powder and 52-62% of refined small molecular peptides with the molecular weight of 1000D-180D.

The production process comprises the following steps:

(3) Putting n kilograms of the taken donkey milk powder finished product and n kilograms of the taken refined small molecular peptide with the molecular weight of between 1000D and 180D into a conical stainless steel container to be uniformly stirred for later use.

(5) And packaging and warehousing the manufactured product after the product is qualified according to the requirements and the detection.

It is to be understood that the above-described embodiment of the present invention is merely an example for clearly illustrating the present invention, and is not intended to limit the embodiments of the present invention. It will be apparent to those skilled in the art that other variations and modifications can be made on the above description without departing from the spirit or scope of the invention, and it is intended to cover all such modifications and variations as fall within the true spirit and scope of the invention.

Claims

1. The formula milk powder of donkey milk powder and micromolecular peptide is characterized by comprising the following components in percentage by weight: 40-45% of refined donkey milk powder and 48-56% of refined small molecular peptides with the molecular weight of 1000D-180D. The preferable proportion is as follows: 38-41% of refined donkey milk powder and 52-62% of refined small molecular peptides with the molecular weight of 1000D-180D.

2. The donkey milk powder and small molecular peptide formula milk powder according to claim 1 is characterized in that the production process comprises the following steps:

(1) taking n kg of refined donkey milk powder for later use.